SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
Status:
Completed
Trial end date:
2018-03-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effectiveness, safety and tolerability of a
combination drug product (SM-1) containing diphenhydramine, zolpidem and lorazepam, in adult
participants who sometimes have difficulty in falling asleep or staying asleep, but who do
not have chronic insomnia. Participants will receive SM-1, or a combination of
diphenhydramine and zolpidem, or a combination of diphenhydramine and lorazepam, or placebo
during 4 one-night stays at a sleep center.